https://doi.org/10.55788/8fd66d4e
VISION Cardiac Surgery is a prospective cohort including 15,971 patients from 12 countries [1]. Dr William McIntyre (Population Health Research Institute, Canada) presented an analysis that included participants without a history of AF who either developed post-operative AF or did not. The analysis assessed characteristics associated with AF and clinical events between 30 days and 1 year following surgery. Outcomes were analysed in association with AF at hospital discharge, receiving electrical cardioversion, and estimated AF duration of >72 hours, 48–72 hours, 24–48 hours, and <24 hours.
Thirty-two per cent (n=3,887) of participants in the cohort had post-operative AF. Almost half of these participants had AF lasting <24 hours. The composite outcome of vascular death or stroke in participants with versus without AF was associated with AF at discharge (adjusted HR 1.72; 95% CI 1.03–2.87) and with receiving electrical cardioversion (adjusted HR 2.18; 95 %CI 1.16–4.11) but not with the other characteristics.
Additionally, the development of stroke was associated with AF lasting >72 hours only (adjusted HR 2.42; 95% CI 1.15–5.09), while the development of congestive heart failure was associated with the presence of AF at discharge only (adjusted HR 2.63; 95% CI 1.49–4.63). Finally, all-cause mortality in participants with AF versus participants without AF was associated with AF at discharge (adjusted HR 1.83; 95% CI 1.10–3.05) and receiving electrical cardioversion (adjusted HR 2.81; 95% CI 1.67-4.73).
“In patients with new-onset, post-operative AF following cardiac surgery, longer durations of AF appear to be markers of cardiac events; electrical cardioversion appears to be a marker of risk but only for all-cause mortality,” concluded Dr McIntyre.
- McIntyre WF, et al. Association of the pattern of new-onset post-operative atrial fibrillation with adverse clinical events over 1 year follow-up: insights from the VISION Cardiac Surgery Cohort. Atrial fibrillation: clinical 1. EHRA Congress 2024, 7–9 April, Berlin, Germany.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« Smartphone rhythm monitoring optimises AF management following cardiac surgery Next Article
Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence »
« Smartphone rhythm monitoring optimises AF management following cardiac surgery Next Article
Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence »
Table of Contents: EHRA 2024
Featured articles
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Personalising Ablation Techniques
Ablate-by-LAW: CT-determined left atrial wall thickness for ablation titration in atrial fibrillation
Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation
Style-AF: Improved outcomes with vascular closure versus figure-of-eight suture
Advantage of PREVENTIVE ablation plus implantable cardioverter-defibrillator in ischaemic cardiomyopathy
ASTRO AF: No benefit of staged left atrial appendage isolation cryoballoon ablation over radiofrequency ablation
Innovative Ablation Strategies
Pulsed-field ablation vs high-power short-duration radiofrequency in paroxysmal AF
CryoCure-VT: Endocardial ultra-low temperature cryoablation effective in sustained monomorphic ventricular tachycardia
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
MRI head-to-head comparison of lesion quality following various ablation techniques
“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation
Post-Ablation Recurrence
AF burden versus classical AF classification in predicting arrhythmia recurrence
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence
Factors associated with negative outcomes in post-operative atrial fibrillation
Arrhythmia Technologies
Smartphone rhythm monitoring optimises AF management following cardiac surgery
SMART-AV and SMART-CRT: Improved cardiac outcomes with algorithm-adapted atrioventricular delay
Premature battery depletion can affect a quarter of subcutaneous cardioverter defibrillators
New atrial fibrillation associated with a high risk of major cardiovascular outcomes
Related Articles
January 14, 2022
New developments in remote diagnostics and monitoring of AF
November 30, 2021
AHA 2021 Highlights Podcast
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com